Centenarian stroke treated with tissue-type plasminogen activator

被引:14
|
作者
Gorman, MJ
Tanne, D
Lewandowski, CA
机构
[1] Wayne State Univ, Sch Med, Dept Neurol, Stroke Program, Detroit, MI 48201 USA
[2] Henry Ford Hlth Sci Ctr, Dept Emergency Med, Detroit, MI USA
[3] Chaim Sheba Med Ctr, Dept Neurol, Stroke Unit, IL-52621 Tel Hashomer, Israel
关键词
stroke; thrombolysis; elderly; tissue-type plasminogen activator;
D O I
10.1159/000057857
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Elderly patients with acute ischemic stroke often do worse than younger counterparts independent of thrombolytic therapy. Further, tissue-type plasminogen activator, (t-PA) is frequently withheld from the very old. This may be the result of comorbid conditions prohibiting its use or possibly the fear of causing more harm than good. We present a case of a 100-year-old woman who was treated with t-PA for acute ischemic stroke with rapid resolution of symptoms. Case Description: A 100 year-old woman presented to the emergency department with slurred speech, right hemiparesis and right hemisensory loss. Computed tomography revealed neither hemorrhage nor early ischemic changes. Intravenous t-PA was administered at 0.9 mg/kg 3 min prior to the 3-hour limit. She improved rapidly (NIHSS from 12 on admission to 4 at 1 month) and was discharged to the care of her family after 4 hospital days. Conclusion: Intravenous thrombolysis may be beneficial in the very elderly and should be considered in any eligible elderly patients with acute ischemic stroke, with a risk/benefit analysis individualized to each case. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:285 / 287
页数:3
相关论文
共 50 条
  • [1] Tissue-type plasminogen activator as a therapeutic target in stroke
    Gravanis, Iordanis
    Tsirka, Stella E.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (02) : 159 - 170
  • [2] Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
    Suzuki, Yasuhiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 113 (03) : 203 - 207
  • [3] Tissue-type plasminogen activator
    Pittman, GL
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (10) : 1377 - 1377
  • [4] Pharmacological study of tissue-type plasminogen activator in ischemic stroke
    Suzuki, Yasuhiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 10P - 10P
  • [5] TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    MCDONALD, C
    SHUMAN, M
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1985, 366 (09): : 823 - 824
  • [6] Human tissue-type plasminogen activator
    Kruithof, Egbert K. O.
    Dunoyer-Geindre, Sylvie
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 112 (02) : 243 - 254
  • [7] The Tissue-Type Plasminogen Activator Story
    Collen, D.
    Lijnen, H. R.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (08) : 1151 - 1155
  • [8] TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    COLLEN, D
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1987, 45 (02) : 198 - 201
  • [9] Is tissue-type plasminogen activator a neuromodulator?
    Fernández-Monreal, M
    López-Atalaya, JP
    Benchenane, K
    Léveillé, F
    Cacquevel, M
    Plawinski, L
    MacKenzie, ET
    Bu, GJ
    Buisson, A
    Vivien, D
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 25 (04) : 594 - 601
  • [10] TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    TURAZZA, FM
    POGNA, M
    [J]. MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1990, 10 (01): : 75 - 78